Ontogeny of dopamine D3 receptors in the nucleus accumbens of the rat-Reference-Cited by-同舟云学术

Ontogeny of dopamine D3 receptors in the nucleus accumbens of the rat

Published:1997-02 Issue:1 Volume:223 Page:13-16
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Stanwood Gregg D,McElligot Seamus,Lu Lisha,McGonigle Paul

Publisher

Elsevier BV

Subject

General Neuroscience

Reference23 articles.

1. Dopamine receptor distribution in the rat CNS: elucidation using ant-peptide antisera directed against D1A and D3 subtypes;Ariano;Brain Res.,1994

2. The use of [3H] standards in [125I] autoradiography;Artymyshyn;J. Neurosci. Methods,1990

3. Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3′-iodo-2′-propenyl)amino]tetralin binding to dopamine D3 receptors in rat olfactory tubercle;Burris;J. Pharmacol. Exp. Ther.,1994

4. Postnatal ontogeny of dopamine D3 receptors in the mouse brain: autoradiographic evidence for a transient cortical expression;Demotes-Mainard;Dev. Brain Res.,1996

5. Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain;Diaz;Neuroscience,1995

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Linkers in Bitopic Agonists Shape Bias Profile among Transducers for the Dopamine D2 and D3 Receptors;ACS Pharmacology & Translational Science;2024-07-26

2. Maturation of nucleus accumbens synaptic transmission signals a critical period for the rescue of social deficits in a mouse model of autism spectrum disorder;Molecular Brain;2023-05-24

3. Maturation of Nucleus Accumbens Synaptic Transmission Signals a Critical Period for the Rescue of Social Deficits in a Mouse Model of Autism Spectrum Disorder;2023-02-08

4. Chronic Δ9-tetrahydrocannabinol impact on plasticity, and differential activation requirement for CB1-dependent long-term depression in ventral tegmental area GABA neurons in adult versus young mice;Frontiers in Neuroscience;2023-01-09

5. Current Perspectives on Selective Dopamine D3 Receptor Antagonists/Partial Agonists as Pharmacotherapeutics for Opioid and Psychostimulant Use Disorders;Therapeutic Applications of Dopamine D3 Receptor Function;2022